PMID- 15124902 OWN - NLM STAT- MEDLINE DCOM- 20050125 LR - 20190818 IS - 0300-8177 (Print) IS - 0300-8177 (Linking) VI - 259 IP - 1-2 DP - 2004 Apr TI - Energy metabolism during cutaneous wound healing in immunocompromised and aged rats. PG - 9-14 AB - Cutaneous cells primarily depend upon carbohydrate metabolism for their energy requirement during healing process. But, it may be greatly hampered during various pathological and altered physiological conditions. The present study was therefore undertaken to investigate the intermediate steps of energy metabolism by measuring enzyme activities in the granulation tissues of immunocompromised and aged rats following excision-type of cutaneous injury. The activities of key regulatory enzymes hexokinase (HK), phosphofructokinase (PFK), lactate dehydrogenase (LDH), citrate synthase (CS) and glucose-6 phosphate dehydrogenase (G6PD) have been monitored in the wound tissues of immunocompromised and aged rats at different time intervals (2, 7, 14 and 21 days) of postwounding. The activities of HK and CS were found significantly decreased both in immunocompromised and aged rats as compared to control subjects. However G6PD exhibited an elevated activity at early stage followed by a decreased activity at later phase of healing both in immunocompromised and aged rats. The PFK and LDH demonstrated an upward trend in immunocompromised rats but a decreasing trend in aged rats. Thus, the results suggest that significant alterations in the activities of energy metabolizing enzymes in the granulation tissues in both immunocompromised as well as in aged rats may overall affect the energy availability for cellular activity needed for repair process. Hence, this may perhaps be one of the factor responsible for impaired healing in these subjects. FAU - Gupta, Asheesh AU - Gupta A AD - Division of Pharmacology, Central Drug Research Institute, PO Box No. 173, Lucknow, India. FAU - Manhas, Namratta AU - Manhas N FAU - Raghubir, Ram AU - Raghubir R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Mol Cell Biochem JT - Molecular and cellular biochemistry JID - 0364456 RN - EC 1.1.1.27 (L-Lactate Dehydrogenase) RN - EC 1.1.1.49 (Glucosephosphate Dehydrogenase) RN - EC 2.3.3.1 (Citrate (si)-Synthase) RN - EC 2.7.1.1 (Hexokinase) RN - EC 2.7.1.11 (Phosphofructokinase-1) RN - WI4X0X7BPJ (Hydrocortisone) SB - IM MH - Aging/pathology/*physiology MH - Animals MH - Carbohydrate Metabolism MH - Citrate (si)-Synthase/metabolism MH - Energy Metabolism/*physiology MH - Glucosephosphate Dehydrogenase/metabolism MH - Granulation Tissue/enzymology MH - Hexokinase/metabolism MH - Hydrocortisone/administration & dosage MH - Immunocompromised Host/*physiology MH - Injections, Intramuscular MH - L-Lactate Dehydrogenase/metabolism MH - Male MH - Phosphofructokinase-1/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Skin/*enzymology/pathology MH - Wound Healing/*physiology EDAT- 2004/05/06 05:00 MHDA- 2005/01/26 09:00 CRDT- 2004/05/06 05:00 PHST- 2004/05/06 05:00 [pubmed] PHST- 2005/01/26 09:00 [medline] PHST- 2004/05/06 05:00 [entrez] AID - 10.1023/b:mcbi.0000021339.34784.81 [doi] PST - ppublish SO - Mol Cell Biochem. 2004 Apr;259(1-2):9-14. doi: 10.1023/b:mcbi.0000021339.34784.81.